CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigator Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
35,156 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0490

Pinealon

Filed under Peptides. The bureau holds 161 laboratory returns for this compound from 66 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

66 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
HomopeptideCASE #VI-2026-0760 A 4 10.0 9.9 10.0 21 May 2026 21 May 2026
Sangon BioCASE #VI-2026-0671 A 4 10.0 9.9 10.0 11 Nov 2025 17 Jun 2026
JEEP PeptidesCASE #VI-2026-0457 A 4 10.0 10.0 10.0 6 Feb 2026 11 Jul 2026
Flourishglobal PeptideCASE #VI-2026-0630 A 4 10.0 10.0 10.0 17 Dec 2025 14 Jul 2026
Shanghai Sigma AudleyCASE #VI-2026-0505 A 4 10.0 9.9 10.0 25 Feb 2026 17 Jun 2026
WuXi TIDESCASE #VI-2026-0335 A 4 10.0 9.9 10.0 1 May 2026 6 Jul 2026
SinoPepCASE #VI-2026-0387 A 4 10.0 10.0 10.0 7 Jan 2026 16 Aug 2026
AsymchemCASE #VI-2026-0091 A 4 10.0 9.9 10.0 6 Dec 2025 28 Jul 2026
Shanghai ERP BiotechnologyCASE #VI-2026-0936 A 3 10.0 9.9 10.0 6 Nov 2025 16 May 2026
QYAOBIOCASE #VI-2026-0861 A 3 10.0 9.9 10.0 2 Apr 2026 23 Jun 2026
Shanghai Wibson BiotechnologyCASE #VI-2026-0379 A 3 10.0 10.0 10.0 12 May 2026 8 Jun 2026
Hybio PharmaceuticalCASE #VI-2026-0065 A 3 10.0 9.9 10.0 4 Dec 2025 26 Jul 2026
Sigma-AldrichCASE #VI-2026-0829 A 2 10.0 10.0 10.0 6 Apr 2026 27 Jun 2026
AmbioPharmCASE #VI-2026-0177 A 2 10.0 10.0 10.0 9 Jun 2026 25 Jul 2026
The Naughty NeedleCASE #VI-2026-0432 X 1 10.0 10.0 10.0 13 Feb 2025 13 Feb 2025
Tianjin Finder Chemical TFCCASE #VI-2026-0693 A 5 9.9 9.9 10.0 14 Nov 2025 16 Apr 2026
Kerui PeptidesCASE #VI-2026-0626 A 4 9.9 9.9 10.0 26 Jan 2026 11 Jul 2026
GenScript PeptidesCASE #VI-2026-0860 A 4 9.9 9.9 10.0 6 Feb 2026 2 Aug 2026
BachemCASE #VI-2026-0314 A 3 9.9 9.9 9.9 26 Apr 2026 10 Jul 2026
Thermo Fisher ScientificCASE #VI-2026-0142 A 3 9.9 9.9 9.9 8 Dec 2025 5 Aug 2026
Hubei JianxiangCASE #VI-2026-0048 A 2 9.9 9.9 10.0 5 Jun 2026 23 Jun 2026
Mokemei BiotechnologyCASE #VI-2026-0540 A 2 9.9 9.9 10.0 15 May 2026 22 May 2026
Chinese Peptide CompanyCASE #VI-2026-0184 A 2 9.9 9.9 10.0 22 Jun 2026 14 Jul 2026
PolyPeptide GroupCASE #VI-2026-0143 A 2 9.9 9.9 9.9 7 May 2026 5 Aug 2026
Aavant ResearchCASE #VI-2026-0831 X 1 9.8 9.8 9.8 13 Feb 2025 13 Feb 2025
UtherCASE #VI-2026-0902 X 2 9.3 8.7 10.0 11 Jun 2025 24 May 2026
Yiwu Aozuo Trading CoCASE #VI-2026-0798 X 7 9.0 6.6 10.0 16 Mar 2025 24 May 2026
Changan District Sheng Peptide TradingCASE #VI-2026-0341 X 1 8.6 8.6 8.6 24 Apr 2025 24 Apr 2025
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 A 6 8.4 7.6 10.0 24 May 2026 24 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538 A 5 8.4 6.8 10.0 21 May 2026 21 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704 A 7 8.3 7.3 9.0 24 May 2026 24 May 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 A 5 8.3 6.9 10.0 24 May 2026 24 May 2026
Orbitrex PeptidesCASE #VI-2026-0812 X 1 8.3 8.3 8.3 6 May 2025 6 May 2025
Xingruida XDRCASE #VI-2026-0898 X 4 8.0 5.5 10.0 7 May 2025 19 Jan 2026
Pura PeptidesCASE #VI-2026-0307 X 1 7.8 7.8 7.8 2 Jul 2025 2 Jul 2025
Limitless Life NootropicsCASE #VI-2026-0980 X 2 7.6 6.5 8.7 11 Jun 2025 20 May 2026
HK PeptidesCASE #VI-2026-0140 X 1 7.6 7.6 7.6 2 Apr 2025 2 Apr 2025
Shanghai Sigma Audley SSACASE #VI-2026-0486 A 3 7.5 6.5 8.1 24 May 2026 24 May 2026
Allen Biotechnology Co ABCCASE #VI-2026-0709 X 1 7.5 7.5 7.5 7 May 2025 7 May 2025
Eros PeptidesCASE #VI-2026-0918 X 1 7.4 7.4 7.4 3 Jun 2025 3 Jun 2025
Peptide HavenCASE #VI-2026-0898 X 1 7.0 7.0 7.0 20 Jun 2025 20 Jun 2025
Loti LabsCASE #VI-2026-0171 X 1 6.9 6.9 6.9 8 Jul 2025 8 Jul 2025
Zenith Jove Peptide ZJCASE #VI-2026-0570 X 2 6.8 6.0 7.5 8 Jul 2025 19 Jan 2026
Kerisite Shenzhen InternationalCASE #VI-2026-0315 X 1 6.7 6.7 6.7 25 Apr 2025 25 Apr 2025
HXNetCASE #VI-2026-0061 X 5 6.6 4.9 8.3 14 Jan 2025 21 May 2026
HealthTide BiotechCASE #VI-2026-0955 X 1 6.5 6.5 6.5 9 Jun 2025 9 Jun 2025
Shanxi Qianyecao Biotech QYCCASE #VI-2026-0189 X 5 6.4 5.4 7.6 28 Mar 2025 24 May 2026
Amino AsylumCASE #VI-2026-0828 X 1 6.3 6.3 6.3 7 May 2025 7 May 2025
ScienceCASE #VI-2026-0636 X 1 5.8 5.8 5.8 8 Jul 2025 8 Jul 2025
HybiopeptidesCASE #VI-2026-0305 X 1 5.7 5.7 5.7 2 Apr 2025 2 Apr 2025
HazelCASE #VI-2026-0392 X 1 5.5 5.5 5.5 3 Jun 2025 3 Jun 2025
YimeiCASE #VI-2026-0081 X 1 5.0 5.0 5.0 17 Dec 2024 17 Dec 2024
Xian Yihang TechnologyCASE #VI-2026-0656 X 3 4.8 3.1 6.9 8 Jul 2025 24 May 2026
Shaanxi Dideu MedichemCASE #VI-2026-0499 X 1 4.6 4.6 4.6 21 May 2025 21 May 2025
Prime PeptidesCASE #VI-2026-0696 X 1 4.4 4.4 4.4 14 Jan 2025 14 Jan 2025
Haikou Mingheng BiotechnologyCASE #VI-2026-0126 X 1 3.8 3.8 3.8 28 Mar 2025 28 Mar 2025
Swiss ChemsCASE #VI-2026-0030 X 1 3.4 3.4 3.4 21 May 2025 21 May 2025
Mix PeptidesCASE #VI-2026-0699 X 1 3.2 3.2 3.2 2 Jul 2025 2 Jul 2025
Xingtai Pukelai Technology CoCASE #VI-2026-0850 X 1 2.2 2.2 2.2 3 Jun 2025 3 Jun 2025
WllyBIOCASE #VI-2026-0470 X 1 1.8 1.8 1.8 8 Jul 2025 8 Jul 2025
Explicit SarmsCASE #VI-2026-0017 X 1 0.4 0.4 0.4 13 Jun 2025 13 Jun 2025
Hebei Chengtong TechnologyCASE #VI-2026-0520 X 1 0.1 0.1 0.1 2 Apr 2025 2 Apr 2025
Weifang Xingbei International TradeCASE #VI-2026-0766 X 1 0.1 0.1 0.1 11 Jun 2025 11 Jun 2025
SubQ SocietyCASE #VI-2026-0716 X 1 0.0 0.0 0.0 24 Apr 2025 24 Apr 2025
LOOKBiotechCASE #VI-2026-0807 X 1 0.0 0.0 0.0 24 Apr 2025 24 Apr 2025
Zhuoyue BiotechnologyCASE #VI-2026-0632 X 1 0.0 0.0 0.0 16 Mar 2025 16 Mar 2025

Open any subject to view the batch-level evidence for Pinealon alone.